ARD Pharma drops 9% as Lupin files application for generic neffy

3 hours ago 1

ARS Pharmaceuticals (NASDAQ:SPRY) is down ~9% in Friday trading after disclosing that Indian drugmaker Lupin has filed an ANDA with the U.S. FDA for a generic version of neffy, an epinephrine nasal spray.
An SEC filing states that Lupin is